Fig. 1From: Long-term effectiveness and safety of lacosamide as adjunctive therapy in children and adolescents with refractory epilepsy: a real-world studyIllustration of the number of patients evaluated at each visit who have been treated with lacosamide treatment at some point during the 3 months and at the 12 monthsBack to article page